Request Demo
Last update 04 Dec 2025
hNPC-01
Last update 04 Dec 2025
Overview
Basic Info
Drug Type Induced pluripotent stem cells (iPSC), Neural stem cell therapy |
Synonyms 人前脑神经前体细胞（浙江霍德）, HNPC 01, HNPC-01 + [1] |
Target- |
Action- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationFast Track (United States) |
Login to view timeline
Related
3
Clinical Trials associated with hNPC-01ChiCTR2500108390
Phase IIa Clinical Study of Human Neural Precursor Cell (hNPC) Transplantation for Ischemic Brain Injury ——A Phase IIa Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of hNPC01 Injection Derived from Human Induced Pluripotent Stem Cells in Improving Hemiplegic Sequelae of Ischemic Stroke
NCT06299033
A Phase 1 Dose-escalation, Single-Center, Open-labeled Study to Evaluate the Safety and Tolerability of Human Induced Pluripotent Stem Cell-derived Human Forebrain Neural Progenitor Cell Injection (hNPC01) in Chronic Ischemic Stroke
ChiCTR2500106320
Clinical Trial of Human Neural Precursor Cell (hNPC) Transplantation for Ischemic Brain Injury(——A Clinical Trial Evaluating the Safety, Tolerability, and Efficacy of hNPC01 Injection Derived from Human Induced Pluripotent Stem Cells in Improving Hemiplegic Sequelae of Ischemic Stroke)(phase I)
100 Clinical Results associated with hNPC-01
Login to view more data
100 Translational Medicine associated with hNPC-01
Login to view more data
100 Patents (Medical) associated with hNPC-01
Login to view more data
100 Deals associated with hNPC-01
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Ischemic stroke | Phase 1 | China | 09 Nov 2023 | |
| stroke; sequelae | Phase 1 | China | 09 Nov 2023 | |
| Epilepsy | Preclinical | China | 01 Aug 2025 | |
| Hemorrhagic stroke | Preclinical | China | 01 Aug 2025 | |
| Brain Injuries, Traumatic | Preclinical | China | 25 Jul 2022 | |
| Cerebral Palsy | Preclinical | China | 25 Jul 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free